Corcept Therapeutics director Daniel N. Swisher Jr. sells $111,105 in common shares

CORT•2026-11-13

Director Daniel N. Swisher Jr. sold 1,500 Corcept Therapeutics shares at $74.07 each on Nov. 10, 2026, and had no directly owned common shares remaining after the transactions, according to a Nov. 13 filing.

1. Share transactions

Swisher sold 1,500 common shares at $74.07 each on Nov. 10, 2026. That day, he also exercised options for 1,100 shares at $14.08 each and 400 shares at $10.50 each. A Nov. 13 filing showed no directly owned common stock remaining following the transactions.

Sources

Corcept Therapeutics director Daniel N. Swisher Jr. sells $111,105 in common shares

Sec

Corcept Therapeutics director Daniel N. Swisher Jr. sells $111,105 in common shares

1. Share transactions

Related News

Nebius Group Chief Revenue Officer Marc Boroditsky reports sale of $1.04 million in common shares

Brookfield Property Partners’ Q3 2026 net loss widens to USD 617 million on retail valuation losses

US SEC proposes scaling back rules on executive pay disclosure

Sources

Corcept Therapeutics director Daniel N. Swisher Jr. sells $111,105 in common shares

BTQ Technologies publishes update to financial calendar

Westlake declares quarterly dividend of $0.533 per share